You have 9 free searches left this month | for more free features.

Recurrent gynecological cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Gynecological Cancer, Metastatic Cervical Cancer, Metastatic Ovarian Cancer Trial in Boston (Durvalumab, Tremelimumab,

Terminated
  • Recurrent Gynecological Cancer
  • +10 more
  • Boston, Massachusetts
    Martin King
Oct 4, 2022

Cervical Cancer Trial in Beijing (BL-B01D1, SI-B003)

Not yet recruiting
  • Cervical Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Aug 16, 2023

Gynecological Malignant Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)

Not yet recruiting
  • Gynecological Malignant Tumor
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University ShangHai Cancer Center
Apr 9, 2023

Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

Not yet recruiting
  • Ovarian Neoplasms
  • +5 more
  • (no location specified)
Sep 3, 2023

Gynecological Cancer Patients Receiving Immunotherapy

Recruiting
  • Gynecologic Cancer
  • +2 more
    • Orlando, Florida
      AdventHealth Cancer Institute
    Oct 13, 2021

    Gynecological Malignancies Trial in Beijing (BL-M07D1)

    Not yet recruiting
    • Gynecological Malignancies
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Nov 15, 2023

    Gynecological Cancer Trial in Beijing, Chengdu (Penpulimab, Anlotinib)

    Not yet recruiting
    • Gynecological Cancer
    • Beijing, Beijing, China
    • +1 more
    Dec 28, 2021

    Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

    Not yet recruiting
    • Endometrioid Cancer
    • +3 more
    • VS-6766 + defactinib
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center
    Aug 19, 2022

    Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Shanghai, Shanghai, China
      Huadong Hospital Affiliated to Fudan University
    Jun 30, 2022

    Whey Protein, Postoperative Outcomes, Gynecological Cancer Surgery Trial in Phaya Thai (whey protein supplement)

    Recruiting
    • Whey Protein
    • +2 more
    • whey protein supplement
    • Phaya Thai, Ratchathewi, Thailand
      Rajavithi
    Sep 6, 2023

    Construction of Gynecological Tumor Organoids

    Not yet recruiting
    • Gynecologic Cancer
    • Organoid
    • construction of organoids from gynecological tumor
    • (no location specified)
    Nov 23, 2023

    Gynecologic Cancer, Cancer Related Pain, Cancer Pain Trial in Jakarta Pusat, Jakarta (Electroacupuncture)

    Recruiting
    • Gynecologic Cancer
    • +2 more
    • Electroacupuncture
    • Jakarta Pusat, DKI Jakarta, Indonesia
    • +2 more
    Oct 4, 2023

    High Grade Serous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Cambridge (Upifitimab rilsodotin,

    Recruiting
    • High Grade Serous Ovarian Cancer
    • +2 more
    • Upifitimab rilsodotin
    • Placebo
    • Phoenix, Arizona
    • +40 more
    Jan 25, 2023

    Psychological Trial in Alexandria (a psycho educational intervention program, the routine care)

    Recruiting
    • Psychological
    • a psycho educational intervention program
    • the routine care
    • Alexandria, Bab Sharqi, Egypt
      El-Shatby University Hospital
    Jul 19, 2023

    Gynecologycal Cancer, Cancer Related Pain, Cancer Pain Trial in Jakarta Pusat, Jakarta (Press Needle Acupuncture)

    Recruiting
    • Gynecologycal Cancer
    • +2 more
    • Press Needle Acupuncture
    • Jakarta Pusat, DKI Jakarta, Indonesia
    • +2 more
    Nov 3, 2023

    Gynecologic Cancer, Cancer Related Pain, Cancer Pain Trial in Jakarta (Manual Acupuncture)

    Recruiting
    • Gynecologic Cancer
    • +3 more
    • Manual Acupuncture
    • Jakarta, DKI Jakarta, Indonesia
      Suryamin Hung
    Oct 4, 2023

    Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

    Not yet recruiting
    • Ovarian Cancer Recurrent
    • Fluzopril Combined With Apatinib
    • (no location specified)
    Oct 22, 2023

    Immunotherapy-related CRP Kinetics in Metastatic Gynecological

    Recruiting
    • Gynecological Malignancies
    • +4 more
      • Tuebingen, Germany
        Department of Women's Health
      Jun 13, 2023

      Ovarian Cancer Prevention Trial in Kfar Saba (salpingectomy)

      Completed
      • Ovarian Cancer Prevention
      • salpingectomy
      • Kfar Saba, Israel
        Meir medical center
      Sep 4, 2023

      Among Physical and Psychological Status, Social Support,

      Enrolling by invitation
      • Gynecologic Cancer
        • Taipei, Taiwan
          National Taiwan University
        Mar 8, 2023

        Microbiome, Recurrent Pregnancy Loss Trial in Ashdod (coulture)

        Not yet recruiting
        • Microbiome
        • Recurrent Pregnancy Loss
        • coulture
        • Ashdod, Israel
          Assuta Ashdod University Hospital
        Nov 3, 2022

        Clinical Outcomes in Gynecological Cancer Patients.

        Recruiting
        • Gynecologic Cancer
        • NGS tests
        • Naples, Italy
          Istituto Nazionale Tumori, IRCCS, Fondazione G Pascale
        Feb 21, 2023

        Medical Imaging in Gynecological Cancer (PRODIGYN)

        Not yet recruiting
        • Cervix Cancer
        • +2 more
        • FDG-PET/CT and FDG-PET/MRI
        • (no location specified)
        May 2, 2023

        Metastatic or Recurrent Gynecological Tumors Trial in Shanghai (Autologous Tumor Infiltrating Lymphocyte Injection (GT202))

        Recruiting
        • Metastatic or Recurrent Gynecological Tumors
        • Autologous Tumor Infiltrating Lymphocyte Injection (GT202)
        • Shanghai, Shanghai, China
          The Obstetrics and Gynecology Hospital of Fudan University
        Feb 11, 2022

        Adenocarcinomas, Recurrent Gynecological Trial in Singapore (pembrolizumab and lenvatinib)

        Recruiting
        • Adenocarcinomas
        • Recurrent Gynecological
        • pembrolizumab and lenvatinib
        • Singapore, Singapore
          National University Hospital
        Oct 13, 2021